

Transseptal Mitral Valve-in-Valve Procedure, Complete vs. Culprit-Only Revascularization in Older Patients, Hypertensive Pregnancy and MI Risk
7 snips Nov 13, 2024
Discover the latest advancements in transseptal mitral valve-in-valve procedures, showcasing impressive outcomes from recent studies. Dive into the debate over complete versus culprit-only revascularization methods for older patients facing myocardial infarction. Plus, explore the intriguing connections between hypertensive pregnancy and heightened risks of coronary artery disease in women. This insightful discussion brings together cutting-edge cardiovascular research and important implications for patient care.
AI Snips
Chapters
Transcript
Episode notes
Mitral Valve-in-Valve Success
- Transseptal mitral valve-in-valve procedures show positive outcomes and trends.
- Mortality and complication rates decreased with growing expertise and technology.
Complete Revascularization Benefits
- Complete revascularization benefits older MI patients, both STEMI and non-STEMI.
- This is supported by the FIRE trial, showing reduced primary and secondary endpoints.
Pregnancy Hypertension and Heart Risk
- Hypertensive disorders during pregnancy increase the risk of future coronary events.
- Women with such disorders experience coronary events about seven years earlier.